Becker's Spine Review

July/August Spine Review 2018

Issue link: https://beckershealthcare.uberflip.com/i/1013189

Contents of this Issue

Navigation

Page 2 of 51

Level I Evidence Is Adding Up. 2 2 2 Prospective, Randomized Studies Different Countries Standard Treatments (decompression alone and fusion) IN AGAINST ACROSS coflex is Statistically Superior Compared to Decompression Alone ^ coflex is the First and Only Lumbar Spinal Device with Level I Evidence: www.paradigmspine.com | www.coflexsolution.com ^ For Composite Clinical Success (CCS) at 2 years (p=0.017). Claims based on ESCADA data, published in Journal of Neurosurgery: Spine. Volume 28 Issue 4, April 2018. CCS is a binary outcome measure in which all 4 components must be achieved: 1) ODI success with improvement > 15 points; 2) survivorship with no secondary surgical interventions or lumbar injections; 3) neurological maintenance or improvement without worsening; and 4) no device- or procedure-related severe adverse events. coflex® and Interlaminar Stabilization® are registered trademarks of Paradigm Spine, LLC The exclusive Posterior Lumbar Motion Preservation Solution with Proven Long-Term Outcomes for Durable Pain Relief and Stability For training opportunities, contact us at training@paradigmspine.com See the evidence at www.paradigmspine.com

Articles in this issue

Links on this page

view archives of Becker's Spine Review - July/August Spine Review 2018